NCT07469202 2026-03-13CYTALUX Dose Extension StudyOn Target Laboratories, LLCPhase 4 Not yet recruiting106 enrolled
NCT05184712 2026-03-04Phase 3 Clinical Study of AK112 for NSCLC PatientsAkesoPhase 3 Active not recruiting322 enrolled